Cancer Check Labs, a leader in multi-cancer early detection, is proud to announce its expansion into New York, furthering its mission to make early detection cancer screening accessible to more communities across the United States.
The Cancer Check blood test screens for more than 200 types of solid tumor cancers and has detected cancer before symptoms appear, as early as Stage 0, when there is a 99% survival rate. The addition of New York means the simple blood test is now available in all 48 continental states.
Health Technology Insights: Stratasys 3D-Printed Eyelid Surgery Models Debut in Europe
“We are excited to continue our expansion across America by adding New York,” said Sumit Rai, CEO, Chairman, & Founder of Cancer Check Labs. “Early cancer detection saves lives, and our expansion into New York represents not only our commitment to this state but also a key step toward making cancer screening a standard part of our healthcare system.”
Health Technology Insights: Altera Digital Health Launches Sunrise Thread AI Scribe
Cancer remains the second leading cause of death in the United States. The American Cancer Society estimates that over 618,000 people will die from cancer in 2025. Early cancer detection improves survival rates and treatment outcomes. The Cancer Check test is a quick and easy blood draw that identifies tumor-based cancers at their earliest stages, allowing individuals to receive timely intervention if needed.
Health Technology Insights: VahatiCor Secures Series B to Advance A-FLUX for Heart Care
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- PR Newswire
